Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with ...

The rise in human life expectancy has slowed down across Europe since 2011, according to research from the University of East Anglia (UEA). A new study, published in The Lancet Public Health, reveals ...

A new study found that a drug recently approved to treat type 2 diabetes and kidney disease in patients with additional ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

I have spoken to many people who are excited about Robert F. Kennedy Jr.’s promises to improve the safety of our food and to promote the health and wellness of our country. These are certainly worthy ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has approved Susvimo® (ranibizumab injection) 100 mg/mL for the treatment of diabetic macular edema ...

Health experts warn of a rise in alcohol-related cancers in India, linking alcohol consumption to over 20 types of cancer, ...

An offensive by M23 fighters is disrupting health services and displacing people in a region already beset by health ...

The report detailed 12 questions that patients should discuss with their physician that can help protect the brain from ...

Ignoring structural inequities in food system transformations risks offsetting potential gains. We summarize current evidence on the context-dependent implications of EAT-Lancet goals and propose six ...